Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease

Autoimmunity Reviews

Volumn 14, Issue 5, 2015, Pages 429-437

  Ruscitti, Piero ^a   Cipriani, Paola ^a   Di Benedetto, Paola ^a   Ciccia, Francesco ^b   Liakouli, Vasiliki ^a   Carubbi, Francesco ^a   Berardicurti, Onorina ^a   Rizzo, Aroldo ^c   Triolo, Giovanni ^b   Giacomelli, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c Ospedali Riuniti Villa Sofia Cervello   (Italy)

Author keywords

Adult onset Still's disease; Hyperferritinemia; Macrophage activation syndrome

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CD68 ANTIGEN; FERRITIN; H FERRITIN; L FERRITIN; UNCLASSIFIED DRUG; APOFERRITIN;

ADULT; ADULT ONSET STILL DISEASE; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FERRITIN BLOOD LEVEL; HEPATOMEGALY; HUMAN; HUMAN TISSUE; HYPERFERRITINEMIA; HYPERTRANSAMINASEMIA; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MACROPHAGE ACTIVATION SYNDROME; MALE; MORTALITY; PROTEIN EXPRESSION; TISSUE LEVEL; ANIMAL; BONE MARROW; CHEMISTRY; LIVER; METABOLISM; ONSET AGE;

ADULT; AGE OF ONSET; ANIMALS; APOFERRITINS; BONE MARROW; HUMANS; LIVER; MACROPHAGE ACTIVATION SYNDROME; STILL'S DISEASE, ADULT-ONSET;

EID: 84925121723     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.01.004     Document Type: Review

References (68)

1. Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol 2008, 22:773-792.
2. Mahroum N., Mahagna H., Amital H. Diagnosis and classification of adult Still's disease. J Autoimmun 2014, 48-49:34-37.
3. Zhu G., Liu G., Liu Y., et al. Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients. J Clin Rheumatol 2009, 15:284-288.
4. Colafrancesco S., Priori R., Alessandri C., Perricone C., Pendolino M., Picarelli G., et al. IL-18 serum level in adult onset Still's disease: a marker of disease activity. Int J Inflamm 2012, 2012:156890.
5. Maria A.T., Le Quellec A., Jorgensen C., Touitou I., Rivière S., Guilpain P. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. Autoimmun Rev 2014, 13:1149-1159.
6. Efthimiou P., Kadavath S., Mehta B. Life-threatening complications of adult-onset Still's disease. Clin Rheumatol 2014, 33:305-314.
7. Ota T., Higashi S., Suzuki H., et al. Increased serum ferritin levels in adult Still's disease. Lancet 1987, 1:562-563.
8. Fautrel B. Ferritin levels in adult Still's disease: any sugar?. Joint Bone Spine 2002, 69:355-357.
9. Cohen L.A., Gutierrez L., Weiss A., et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 2010, 116:1574-1584.
10. Torti F.M., Torti S.V. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516.
11. Wang W., Knovich M.A., Coffman L.G., et al. Serum ferritin: past, present and future. Biochim Biophys Acta 1800, 2010:760-769.
12. Recalcati S., Invernizzi P., Arosio P., Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 2008, 30:84-89.
13. Kuchroo V.K., Umetsu D.T., DeKruyff R.H., Freeman G.J. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 2003, 3:454-462.
14. Chakravarti S., Sabatos C.A., Xiao S., et al. Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med 2005, 202:437-444.
15. Knickelbein J.E., de Souza A.J., Tosti R., et al. Cutting edge: inhibition of T cell activation by TIM-2. J Immunol 2006, 177:4966-4970.
16. Smith E.P., Shanks K., Lipsky M.M., et al. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol 2011, 12:30.
17. Rodriguez-Manzanet R., DeKruyff R., Kuchroo V.K., et al. The costimulatory role of TIM molecules. Immunol Rev 2009, 229:259-270.
18. Choi J.-H., Suh C.-H., Lee Y.-M., et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003, 30:2422-2427.
19. Gerfaud-Valentin M., Jamilloux Y., Iwaz J., et al. Adult-onset Still's disease. Autoimmun Rev 2014, 13:708-722.
20. Ramos-Casals M., Brito-Zerón P., López-Guillermo A., et al. Adult haemophagocytic syndrome. Lancet 2014, 383(9927):1503-1516.
21. Zandman-Goddard G., Shoenfeld Y. Ferritin in autoimmune diseases. Autoimmun Rev 2007, 6:457-463.
22. Tristano A.G. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases. Med Sci Monit 2008, 14(3):RA27-RA36.
23. Sawhney S., Woo P., Murray K.J. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child 2001, 85:421-426.
24. Behrens E.M. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?. Autoimmun Rev 2008 Feb, 7(4):305-308.
25. Janka G.E., Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematol Am Soc Hematol Educ Program 2013, 2013:605-611.
26. Janka G.E., Lehmberg K. Hemophagocytic syndromes - an update. Blood Rev 2014 Mar 22, [pii: S0268-960X(14)00028-9, Epub ahead of print]. 10.1016/j.blre.2014.03.002.
27. Bode S.F., Lehmberg K., Maul-Pavicic A., et al. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther 2012, 14:213.
28. Rosário C., Zandman-Goddard G., Meyron-Holtz E.G., et al. The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 2013, 11:185.
29. Colafrancesco S., Priori R., Alessandri C., Astorri E., Perricone C., Blank M., et al. The hyperferritinemic syndromes and CD163: a marker of macrophage activation. Isr Med Assoc J 2014 Oct, 16(10):662-663.
30. Yamaguchi M., Ohta A., Tsunematsu T., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992, 19:424-430.
31. Filipovich A.H. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program 2009, 127-131.
32. Loh N.K., Lucas M., Fernandez S., et al. Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra. Intern Med J 2012, 42:1358-1362.
33. Kobayashi M., Takahashi Y., Yamashita H., et al. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. Mod Rheumatol 2011, 21:92-96.
34. Puéchal X., DeBandt M., Berthelot J.M., et al. Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken) 2011, 63:155-159.
35. Mavragani C.P., Spyridakis E.G., Koutsilieris M. Adult-onset Still's disease: from pathophysiology to targeted therapies. Int J Inflamm 2012, 879020.
36. Cipriani P., Ruscitti P., Carubbi F., et al. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series. Clin Rheumatol 2014, 33:49-55.
37. Pascual V., Allantaz F., Arce E., et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005, 201:1479-1486.
38. Chen D.Y., Lan J.L., Lin F.J., et al. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol 2004, 31:2189-2198.
39. Maruyama J., Inokuma S. Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases. J Rheumatol 2010, 37:967-973.
40. Torti S.V., Kwak E.L., Miller S.C., et al. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem 1988, 263:12638-12644.
41. Smirnov I.M., Bailey K., Flowers C.H., et al. Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity. Am J Physiol 1999, 277(2 Pt 1):L257-L263.
42. Wei Y., Miller S.C., Tsuji Y., et al. Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem Biophys Res Commun 1990, 169:289-296.
43. Piñero D.J., Hu J., Cook B.M., et al. Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool. Biochim Biophys Acta 2000, 1497:279-288.
44. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat Immunol 2011, 12:715-723.
45. Bejar R. Clinical and genetic predictors of prognosis in myelodysplastic syndromes. Haematologica 2014, 99:956-964.
46. Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
47. Zoller E.E., Lykens J.E., Terrell C.E., et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 2011, 208:1203-1214.
48. Gerfaud-Valentin M., Maucort-Boulch D., Hot A., Iwaz J., Ninet J., Durieu I., et al. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore) 2014, 93:91-99.
49. Pouchot J., Sampalis J.S., Beaudet F., et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991, 70:118-136.
50. Aricò M., Janka G., Fischer A., et al. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996, 10:197-203.
51. Arlet J.B., Le T.H., Marinho A., et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis 2006, 65:1596-1601.
52. Pamuk O.N., Pamuk G.E., Usta U., et al. Hemophagocytic syndrome in one patient with adult-onset Still's disease. Presentation with febrile neutropenia. Clin Rheumatol 2007, 26:797-800.
53. Nadia E.A., Carvalho J.F., Bonfa E., et al. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis. IMAJ 2009, 11:635-636.
54. Stern A., Riley R., Buckley L. Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy. J Clin Rheumatol 2001, 7:252-256.
55. Bresgen N., Ohlenschläger I., Fiedler B., et al. Ferritin - a mediator of apoptosis?. J Cell Physiol 2007, 212:157-164.
56. Priori R., Barone F., Alessandri C., et al. Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis. Rheumatology (Oxford) 2011, 50:776-780.
57. Knovich M.A., Storey J.A., Coffman L.G., et al. Ferritin for the clinician. Blood Rev 2009, 23:95-104.
58. Chen T.T., Li L., Chung D.H., et al. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med 2005, 202:955-965.
59. Colafrancesco S., Priori R., Alessandri C., et al. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia. Immunol Res 2014, 60:177-183.
60. Akritidis N., Giannakakis Y., Sakkas L. Very high serum ferritin levels in adult-onset Still's disease. Br J Rheumatol 1997, 36:608-609.
61. Akritidis N., Giannakakis I., Giouglis T. Ferritin levels and response to treatment in patients with adult Still's disease. J Rheumatol 1996, 23:201-202.
62. Lee S.-W., Park Y.-B., Song J.-S., Lee S.-K. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease. J Rheumatol 2009, 36:156-162.
63. Ichida H., Kawaguchi Y., Sugiura T., et al. Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18. Arthritis Care Res 2014, 66:642-646.
64. Emmenegger U., Schaer D.J., Larroche C., et al. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005, 135:299-314.
65. Lin T.F., Ferlic-Stark L.L., Allen C.E., et al. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 2011, 56:154-155.
66. Takahashi N., Chubachi A., Kume M., et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001, 74:209-213.
67. Fardet L., Galicier L., Vignon-Pennamen M.D., et al. Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome. Br J Dermatol 2010, 162:547-553.
68. Zeng T., Zou Y-Q Wu.M.-F., et al. Clinical features and prognosis of adult-onset Still's disease: 61 cases from China. J Rheumatol 2009, 36:1026-1031.